Chimeric non-antigen receptors in T cell-based cancer therapy
Adoptively transferred T cell-based cancer therapies have shown incredible promise in treatment of various cancers. So far therapeutic strategies using T cells have focused on manipulation of the antigen-recognition machinery itself, such as through selective expression of tumor-antigen specific T c...
Main Authors: | Andrew Kent, Eduardo Davila, Jitao Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/8/e002628.full |
Similar Items
-
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
by: Daniel Sur, et al.
Published: (2020-01-01) -
Chimeric Antigen Receptor-T Cell Therapy
by: Jochen Buechner, et al.
Published: (2018-02-01) -
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
by: Xiao Han, et al.
Published: (2019-11-01) -
Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
by: Yan W, et al.
Published: (2019-09-01) -
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
by: Stefan Stoiber, et al.
Published: (2019-05-01)